Stem cell induced inflammatory hypertrophy of the cauda equina
- PMID: 35309384
- PMCID: PMC8931292
- DOI: 10.1016/j.radcr.2022.02.021
Stem cell induced inflammatory hypertrophy of the cauda equina
Abstract
Stem cell therapy can present clinicians with challenging clinical scenarios, as access to such treatments outpaces the research into their efficacy and safety due to the burgeoning trend of international travel to acquire stem cell therapy, or "stem cell tourism." Treatment of neurologic conditions remains an enticing potential application of stem cell therapy, often administered intrathecally. In response to such therapy, multiple adverse events have been described in the literature, including neoplasms, demyelinating disease, and seizures, among others. We present a case of symptomatic inflammatory cauda equina nerve root hypertrophy due to intrathecal stem cell infusion, representing a rare but significant complication.
Keywords: Adverse effects; Inflammatory nerve root hypertrophy; Intrathecal stem cell; Stem cell tourism.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures
References
-
- Aoun SG, Reyes VP, El Ahmadieh TY, Davies M, Patel AR, Ban VS, et al. Stem cell injections for axial back pain: a systematic review of associated risks and complications with a case illustration of diffuse hyperplastic gliosis resulting in cauda equina syndrome. J Neurosurg Spine. 2019;31:906–913. doi: 10.3171/2019.6.SPINE19594. - DOI - PubMed
-
- National Institutes of Health. ClinicalTrials.gov. Accessed 18 December 2021.
Publication types
LinkOut - more resources
Full Text Sources
